Christopher A. Boerner
2012
In 2012, Christopher A. Boerner earned a total compensation of $1.8M as Former EVP, Commercial at Seattle Genetics.
Compensation breakdown
| Non-Equity Incentive Plan | $138,600 |
|---|---|
| Option Awards | $736,763 |
| Salary | $309,298 |
| Stock Awards | $571,640 |
| Other | $7,980 |
| Total | $1,764,281 |
Boerner received $736.8K in option awards, accounting for 42% of the total pay in 2012.
Boerner also received $138.6K in non-equity incentive plan, $309.3K in salary, $571.6K in stock awards and $8K in other compensation.
Rankings
In 2012, Christopher A. Boerner's compensation ranked 3,989th out of 11,487 executives tracked by ExecPay. In other words, Boerner earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,989 out of 11,487 | 65th |
Division Manufacturing | 1,383 out of 4,253 | 68th |
Major group Chemicals And Allied Products | 312 out of 1,198 | 74th |
Industry group Drugs | 186 out of 920 | 80th |
Industry Biological Products, Except Diagnostic Substances | 34 out of 160 | 79th |
Source: SEC filing on April 6, 2015.
Boerner's colleagues
We found five more compensation records of executives who worked with Christopher A. Boerner at Seattle Genetics in 2012.
2012
Clay Siegall
Seattle Genetics
Chief Executive Officer
2012
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2012
Thomas Reynolds
Seattle Genetics
Chief Medical Officer
2012
Todd Simpson
Seattle Genetics
Chief Financial Officer
2012
Jonathan Drachman
Seattle Genetics